The clusterin protein is of particular interest as a potential biomarker of MPS I cardiovascular disease because it is involved in morphologic transformation of vascular smooth muscle cells [29] and present in human atherosclerotic plaques, but not in healthy normal aortas [30]. Here, CLU is linked to Scheie syndrome.